Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global H1N1 (swine flu) Vaccination Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global H1N1 (swine flu) Vaccination Market, by Treatment Type, 2020-2028 (USD Billion)
1.2.3. Global H1N1 (swine flu) Vaccination Market, by Route of Administration, 2020-2028 (USD Billion)
1.2.4. Global H1N1 (swine flu) Vaccination Market, by End User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global H1N1 (swine flu) Vaccination Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global H1N1 (swine flu) Vaccination Market Dynamics
3.1. H1N1 (swine flu) Vaccination Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Public-private partnerships for supply of H1N1 vaccine
3.1.1.2. Government subsidies for vaccine manufacture
3.1.2. Market Challenges
3.1.2.1. High costs & lengthy manufacturing process
3.1.3. Market Opportunities
3.1.3.1. Shift from egg-based to cell-based manufacturing
Chapter 4. Global H1N1 (swine flu) Vaccination Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global H1N1 (swine flu) Vaccination Market, by Treatment Type
6.1. Market Snapshot
6.2. Global H1N1 (swine flu) Vaccination Market by Treatment Type, Performance - Potential Analysis
6.3. Global H1N1 (swine flu) Vaccination Market Estimates & Forecasts by Treatment Type 2019-2028 (USD Billion)
6.4. H1N1 (swine flu) Vaccination Market, Sub Segment Analysis
6.4.1. Influenza
6.4.2. Meningococcal
6.4.3. Cervical Cancer
6.4.4. Pneumococcal
6.4.5. Hepatitis
6.4.6. Measles
6.4.7. Mumps
6.4.8. Rubella
Chapter 7. Global H1N1 (swine flu) Vaccination Market, by Route of Administration
7.1. Market Snapshot
7.2. Global H1N1 (swine flu) Vaccination Market by Route of Administration, Performance - Potential Analysis
7.3. Global H1N1 (swine flu) Vaccination Market Estimates & Forecasts by Route of Administration 2019-2028 (USD Billion)
7.4. H1N1 (swine flu) Vaccination Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Research and Diagnostic Laboratories
7.4.4. Others
Chapter 8. Global H1N1 (swine flu) Vaccination Market, by End User
8.1. Market Snapshot
8.2. Global H1N1 (swine flu) Vaccination Market by End User, Performance - Potential Analysis
8.3. Global H1N1 (swine flu) Vaccination Market Estimates & Forecasts by End User 2019-2028 (USD Billion)
8.4. H1N1 (swine flu) Vaccination Market, Sub Segment Analysis
8.4.1. Intranasal
8.4.2. Conjugate
8.4.3. Attenuated Vaccines
8.4.4. Inactivated Vaccines
8.4.5. Intramuscular Vaccines
8.4.6. Toxoid
Chapter 9. Global H1N1 (swine flu) Vaccination Market, Regional Analysis
9.1. H1N1 (swine flu) Vaccination Market, Regional Market Snapshot
9.2. North America H1N1 (swine flu) Vaccination Market
9.2.1. U.S. H1N1 (swine flu) Vaccination Market
9.2.1.1. Treatment Type estimates & forecasts, 2019-2028
9.2.1.2. Route of Administration estimates & forecasts, 2019-2028
9.2.1.3. End User estimates & forecasts, 2019-2028
9.2.2. Canada H1N1 (swine flu) Vaccination Market
9.3. Europe H1N1 (swine flu) Vaccination Market Snapshot
9.3.1. U.K. H1N1 (swine flu) Vaccination Market
9.3.2. Germany H1N1 (swine flu) Vaccination Market
9.3.3. France H1N1 (swine flu) Vaccination Market
9.3.4. Spain H1N1 (swine flu) Vaccination Market
9.3.5. Italy H1N1 (swine flu) Vaccination Market
9.3.6. Rest of Europe H1N1 (swine flu) Vaccination Market
9.4. Asia-Pacific H1N1 (swine flu) Vaccination Market Snapshot
9.4.1. China H1N1 (swine flu) Vaccination Market
9.4.2. India H1N1 (swine flu) Vaccination Market
9.4.3. Japan H1N1 (swine flu) Vaccination Market
9.4.4. Australia H1N1 (swine flu) Vaccination Market
9.4.5. South Korea H1N1 (swine flu) Vaccination Market
9.4.6. Rest of Asia Pacific H1N1 (swine flu) Vaccination Market
9.5. Latin America H1N1 (swine flu) Vaccination Market Snapshot
9.5.1. Brazil H1N1 (swine flu) Vaccination Market
9.5.2. Mexico H1N1 (swine flu) Vaccination Market
9.6. Rest of The World H1N1 (swine flu) Vaccination Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AstraZeneca
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Novavax, Inc.
10.2.3. Zydus Cadila.
10.2.4. Panacea Biotec Ltd.
10.2.5. Sinovac Biotech Ltd.
10.2.6. Johnson & Johnson Services, Inc.
10.2.7. Green Cross Corp.
10.2.8. Abbott, Pfizer Inc.
10.2.9. Mitsubishi Tanabe Pharma Corporation.
10.2.10. Cipla Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption